These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 7920500

  • 21. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL, Stock KP, Hüdepohl M.
    Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
    [Abstract] [Full Text] [Related]

  • 22. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M.
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [Abstract] [Full Text] [Related]

  • 23. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention.
    Rodríguez de la Serna A, Díaz-Rubio M.
    J Rheumatol; 1994 May; 21(5):927-33. PubMed ID: 8064736
    [Abstract] [Full Text] [Related]

  • 24. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL, Codispoti JR, Nelson EB.
    Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
    [Abstract] [Full Text] [Related]

  • 25. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ, Agrawal NM.
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [Abstract] [Full Text] [Related]

  • 26. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F, Peace K, Gustitus L, Rack MF, Dickson B.
    Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
    [Abstract] [Full Text] [Related]

  • 27. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
    Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB, Stanton DS.
    Ann Intern Med; 1995 Sep 01; 123(5):344-50. PubMed ID: 7625622
    [Abstract] [Full Text] [Related]

  • 28. [Recurrence of gastropathies caused by intake of nonsteroidal anti-inflammatory drugs].
    Karameev AE.
    Ter Arkh; 2003 Sep 01; 75(5):74-8. PubMed ID: 12847904
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of misoprostol in controlling indomethacin induced fecal blood loss in arthritic patients.
    Jallad NS, Cattan A, Weidler DJ.
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug 01; 31(8):376-81. PubMed ID: 8225682
    [Abstract] [Full Text] [Related]

  • 33. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM, Dajani EZ.
    J Assoc Acad Minor Phys; 1992 Aug 01; 3(4):142-8. PubMed ID: 1392409
    [Abstract] [Full Text] [Related]

  • 34. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage.
    Valentini M, Cannizzaro R, Poletti M, Bortolussi R, Fracasso A, Testa V, Sozzi M, Fornasarig M, Bortoluzzi F, Grazioli I.
    J Clin Oncol; 1995 Oct 01; 13(10):2637-42. PubMed ID: 7595718
    [Abstract] [Full Text] [Related]

  • 35. [Evaluation of misoprostol's clinical utility for gastric/duodenal ulcers seen under long-term use of non-steroidal anti-inflammatory drugs (NSAID)--I. Evaluation of mucosal prophylactic effects by a placebo-controlled double blind comparative study].
    Shiokawa Y, Nobunaga M, Saito T, Sakita T, Miwa T, Nakamura K, Gunji A, Aoki K.
    Ryumachi; 1991 Oct 01; 31(5):554-71. PubMed ID: 1767349
    [No Abstract] [Full Text] [Related]

  • 36. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND.
    Ital J Gastroenterol Hepatol; 1999 Oct 01; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS, Stead H, Wallemark CB, Nicholson PA.
    J Rheumatol Suppl; 1991 Mar 01; 28():11-4. PubMed ID: 1903808
    [Abstract] [Full Text] [Related]

  • 40. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
    Simon B, Beckers KH, Biewer W, Bouzo MH, Dammann HG, Gebest HJ, Müller P, Schütz E.
    Z Gastroenterol; 1988 Jun 01; 26(6):310-3. PubMed ID: 3061183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.